Moody Aldrich Partners LLC Trims Position in Crinetics Pharmaceuticals, Inc. $CRNX
Moody Aldrich Partners LLC lessened its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 16.1% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 115,543 shares of the company’s stock after selling 22,253 shares during the period. Moody Aldrich Partners LLC owned 0.12% of Crinetics […]
1 Jan 13:06 · The Markets Daily